SR57667B

DRUG4 trials

Sponsors

Sanofi

Conditions

Alzheimer DiseaseParkinson Disease

Phase 2

Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease

CompletedNCT00220272

SanofiParkinson Disease

Start: 2004-01-31End: 2007-03-31Updated: 2008-12-23

Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease

CompletedNCT00228150

SanofiParkinson Disease

Start: 2003-07-31End: 2006-04-30Updated: 2008-12-23

Study of the Effect of SR57667B in Patients With Alzheimer's Disease

CompletedNCT00285025

SanofiAlzheimer Disease

Start: 2005-03-31End: 2005-09-30Target: 500Updated: 2006-02-01

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

CompletedNCT00285077

SanofiAlzheimer Disease

Start: 2004-03-31End: 2006-11-30Updated: 2008-12-23